The RET fusion-targeted therapy market is set for strong expansion, driven by growing awareness of the oncogenic role of RET ...
Xueqing Hu , Ujjwol Khatri , Tao Shen , and Jie Wu, at University of Oklahoma Health Sciences Center, USA, provides a comprehensive review of the role of the RET (REarranged during Transfection) ...
Xueqing Hu , Ujjwol Khatri , Tao Shen , and Jie Wu, at University of Oklahoma Health Sciences Center, USA, provides a comprehensive review of the role of the RET (REarranged during Transfection) ...
A phase I/II multiple expansion cohort trial of MRTX849 in patients with advanced solid tumors with KRAS G12C mutation. Background: RET gene alterations (mutations and fusions) leading to constitutive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results